1. Home
  2. HOWL vs ATPC Comparison

HOWL vs ATPC Comparison

Compare HOWL & ATPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • ATPC
  • Stock Information
  • Founded
  • HOWL 2017
  • ATPC 2016
  • Country
  • HOWL United States
  • ATPC Malaysia
  • Employees
  • HOWL N/A
  • ATPC N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • ATPC Medical/Nursing Services
  • Sector
  • HOWL Health Care
  • ATPC Health Care
  • Exchange
  • HOWL Nasdaq
  • ATPC Nasdaq
  • Market Cap
  • HOWL 64.5M
  • ATPC 63.0M
  • IPO Year
  • HOWL 2021
  • ATPC N/A
  • Fundamental
  • Price
  • HOWL $0.93
  • ATPC $1.30
  • Analyst Decision
  • HOWL Strong Buy
  • ATPC
  • Analyst Count
  • HOWL 5
  • ATPC 0
  • Target Price
  • HOWL $7.00
  • ATPC N/A
  • AVG Volume (30 Days)
  • HOWL 732.3K
  • ATPC 35.2K
  • Earning Date
  • HOWL 11-04-2025
  • ATPC 11-13-2025
  • Dividend Yield
  • HOWL N/A
  • ATPC N/A
  • EPS Growth
  • HOWL N/A
  • ATPC N/A
  • EPS
  • HOWL N/A
  • ATPC N/A
  • Revenue
  • HOWL N/A
  • ATPC $1,484,905.00
  • Revenue This Year
  • HOWL N/A
  • ATPC N/A
  • Revenue Next Year
  • HOWL N/A
  • ATPC N/A
  • P/E Ratio
  • HOWL N/A
  • ATPC N/A
  • Revenue Growth
  • HOWL N/A
  • ATPC 9.66
  • 52 Week Low
  • HOWL $0.60
  • ATPC $0.90
  • 52 Week High
  • HOWL $2.38
  • ATPC $2.93
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 24.51
  • ATPC 53.31
  • Support Level
  • HOWL $0.89
  • ATPC $1.25
  • Resistance Level
  • HOWL $1.00
  • ATPC $1.45
  • Average True Range (ATR)
  • HOWL 0.11
  • ATPC 0.09
  • MACD
  • HOWL -0.03
  • ATPC 0.01
  • Stochastic Oscillator
  • HOWL 5.58
  • ATPC 41.09

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About ATPC Agape ATP Corporation

Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. Its segments include: Skin care, health and wellness segment includes the provision of health and wellness products and health solution advisory services; and Green energy segment includes providing renewable energy products, technical solutions, installations and maintenance services. It derives maximum revenue from Skin care, health and wellness segment.

Share on Social Networks: